TITLE

Complicaciones hepáticas asociadas at uso de nutrición parenteral

AUTHOR(S)
Villares, J. M. Moreno
PUB. DATE
May 2008
SOURCE
Nutricion Hospitalaria;May2008 Supplement 2, Vol. 23, p25
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Parenteral nutrition associated liver disease (PNALD) is an important problem in patients who require long-term parenteral nutrition as well as in preterm infants. Prevalence varies according to different series. Clinical presentation is different in adults and infants. Although since its first descriptions several hypothesis have been elucidated, the aetiology is not quite clear. It is possible that different factors could be involved. PNALD risk factors can be classified in three groups: 1) those derived from the lack of enteral nutrition stimulus; 2) parenteral nutrition components acting as toxic or the lack of specific nutrients and 3) those due to the underlying disease. If PNALD appears in short-term PN and it presents only as a mild elevation of liver enzymes, there is no need to treat. On the contrary, when direct bilirubin is > 2 mg/dL and lasts longer, there is a need to consider different causes and to minimize risk factors. We review the different approaches to manage PNALD, including optimizing enteral nutrition, modify parenteral solutions, use of specific nutrients -taurine, choline, etc.- or the use of drugs (mainly ursodeoxicolic acid) If liver disease progresses to a cirrhosis a liver transplant must be considered.
ACCESSION #
34050582

 

Related Articles

  • CHOLESTAZA U DZIECKA URODZONEGO PRZEDWCZEÅšNIE — ETIOLOGIA I PRZEBIEG — OPIS PRZYPADKU. Ligenza, Iwona; Jakubowska-Pietkiewicz, Elżbieta; Chlebna-Sokół, Danuta // Przeglad Pediatryczny;2012, Vol. 42 Issue 3, p162 

    Pathological icterus with elevation of direct bilirubin (cholestasis) may be caused by many reasons, but immature liver of a premature child is particularly prone to cholestasis due to various etiological factors. We present a case of a premature infant with cholestasis in the course of...

  • Parenteral Nutrition-Induced Cholestasis in Neonates: Where Does the Problem Lie? Jolin-Dahel, Kheira; Ferretti, Emanuela; Montiveros, Carolina; Grenon, Renee; Barrowman, Nick; Jimenez-Rivera, Carolina // Gastroenterology Research & Practice;2013, p1 

    Background. Parenteral nutrition (PN) is an effective method of nourishing the neonate who is unable to receive full enteral feeds. Cholestasis canbe a complicationof PNandcan lead to severe liverdamage. Aim. We describe our patient population and determine risk factors for developing PN...

  • ¿MEJORA EL USO DE ÁCIDO URSODEOXICÓLICO EL PRONÓSTICO PERINATAL EN MUJERES EMBARAZADAS CON COLESTASIA INTRAHEPÁTICA DEL EMBARAZO? Morgan S., Gonzalo; Villalón S., Valentina; Danilla E., Stefan; ViIlavicencio F., Luis; Kottmann G., Cristián; Illanes L., Sebastian // Revista Chilena de Obstetricia y Ginecología;2007, Vol. 72 Issue 5, p292 

    Intrahepatic cholestasis of pregnancy (ICP) is a disease of the third trimester of pregnancy involving pruritus and elevated bile acid levels. Once thought to be benign for both mother and fetus, lCP has been associated with maternal jaundice and increased rates of fetal morbidity and mortality....

  • Intrahepatic cholestasis of pregnancy. Geenes, Victoria; Williamson, Catherine; Geier, Andreas // World Journal of Gastroenterology;5/7/2009, Vol. 15 Issue 17, p2049 

    Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy-specific liver disorder characterized by maternal pruritus in the third trimester, raised serum bile acids and increased rates of adverse fetal outcomes. The etiology of ICP is complex and not fully understood, but it is likely to result...

  • Effectiveness of perioperative glutamine in parenteral nutrition in patients at risk of moderate to severe malnutrition. Mercadal Orfila, G.; Llop Talaverón, J. M. // Nutricion Hospitalaria;nov/dic2011, Vol. 26 Issue 6, p1305 

    Background & aims: To determine whether perioperative glutamine supplementation of parenteral nutrition (PN) has an impact on morbidity and mortality of patients with previous moderate to severe risk of malnutrition. Methods: A quasi-experimental study was conducted comparing the following...

  • Screening of newborn infants for cholestatic hepatobiliary disease with tandem mass... Mushtaq, Imran; Logan, Stuart // BMJ: British Medical Journal (International Edition);08/21/99, Vol. 319 Issue 7208, p471 

    Provides information on a study which assessed the feasibility of screening for cholestatic hepatobiliary disease and extra hepatic biliary atresia among newborn infants using tandem mass spectrometry. Diagnosis of the disease; Performance of the tandem mass spectrometry; Effect of storage on...

  • Management of neonatal cholestasis: Consensus statement of the pediatric gastroenterology chapter of Indian academy of pediatrics. Bhatia, Vidyut; Bavdekar, Ashish; Matthai, John; Waikar, Yogesh; Sibal, Anupam // Indian Pediatrics;Mar2014, Vol. 51 Issue 3, p203 

    Justification: Neonatal cholestasis is an important cause of chronic liver disease in young children. Late referral and lack of precise etiological diagnosis are reasons for poor outcome in substantial number of cases in India. There is a need to create better awareness among the pediatricians,...

  • Analysis of the histologic features in the differential diagnosis of intrahepatic neonatal cholestasis. Bellomo-Brandao, Maria Angela; Escanhoela, Cecilia A. F.; Meirelles, Luciana R.; Porta, Gilda; Hessel, Gabriel // World Journal of Gastroenterology;1/28/2009, Vol. 15 Issue 4, p478 

    AIM: To compare the histologic features of the liver in intrahepatic neonatal cholestasis (IHNC) with infectious, genetic-endocrine-metabolic, and idiopathic etiologies. METHODS: Liver biopsies from 86 infants with IHNC were evaluated. The inclusion criteria consisted of jaundice beginning at 3...

  • Liver transplantation in α[sub 1] -antitrypsin deficiency. Németh, A. // European Journal of Pediatrics;1999, Vol. 158 Issue 14, pS085 

    Abstract Only a minority of infants born with alpha[sub 1]-antitrypsin deficiency will develop serious liver disease during childhood, mostly but not always after neonatal cholestasis. Early prognosis is difficult and all children have to be followed up carefully. The liver disease progresses...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics